Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
UZEDY: Information from Industry
View All
Jacob S. Ballon, MD, MPH
JCP
Original Research
Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan
December 4, 2024
During up to 4 years of treatment, the combination of olanzapine/samidorphan was safe and well-tolerated, and patients’ symptoms remained stable.
Jacob S. Ballon
,
René S. Kahn
,
Christina Arevalo
, et al
JCP
Original Research
A Systematic Review of Modafinil: Potential Clinical Uses and Mechanisms of Action
April 15, 2006
David Feifel
,
Jacob S. Ballon
JCP
Original Research
The Effects of Novel Antipsychotics on Glucose and Lipid Levels
October 1, 2002
Stephen R. Marder
,
Donna A. Wirshing
,
William C. Wirshing
, et al
